scispace - formally typeset
Search or ask a question
Author

Abdullah

Bio: Abdullah is an academic researcher from Stanford University. The author has an hindex of 1, co-authored 1 publications receiving 5 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: Extracellular vesicles (EVs) have emerged as potential mediators of intercellular communication as discussed by the authors and hold great promise for therapeutic treatments, particularly in treating a potentially fatal autoimmune response and attenuate inflammation.

14 citations


Cited by
More filters
Journal ArticleDOI
01 Jan 2022-Cells
TL;DR: The sources of extracellular vesicles, including plant, salivary and urinary sources which are easily available but less sought after compared with blood and tissue are discussed.
Abstract: The use of extracellular vesicles (EV) in nano drug delivery has been demonstrated in many previous studies. In this study, we discuss the sources of extracellular vesicles, including plant, salivary and urinary sources which are easily available but less sought after compared with blood and tissue. Extensive research in the past decade has established that the breadth of EV applications is wide. However, the efforts on standardizing the isolation and purification methods have not brought us to a point that can match the potential of extracellular vesicles for clinical use. The standardization can open doors for many researchers and clinicians alike to experiment with the proposed clinical uses with lesser concerns regarding untraceable side effects. It can make it easier to identify the mechanism of therapeutic benefits and to track the mechanism of any unforeseen effects observed.

26 citations

Journal ArticleDOI
TL;DR: Extracellular vesicles (EVs) are naturally phospholipid enclosed nanoveicles released by many cells in the body as discussed by the authors, which are stable in circulation, have low immunogenicity, and act as carriers for functionally active biological molecules.
Abstract: Extracellular vesicles (EVs) are naturally phospholipid enclosed nanovesicles released by many cells in the body. They are stable in circulation, have low immunogenicity, and act as carriers for functionally active biological molecules. They interact with target organs and bind to the receptors. Their target specificity is important to use EVs as noninvasive diagnostic and prognostic tools. EVs play a vital role in normal physiology and cellular communication. They are known to protect their cargo from degradation, which makes them important drug carriers for targeted drug delivery. Using EVs with markers and tracking their path in systemic circulation can be revolutionary in using them as diagnostic tools. We will discuss the scope of this in this paper. Although there are limitations in EVs isolation and storage, their high biocompatibility will fuel more innovations to overcome these challenges.

17 citations

Journal ArticleDOI
TL;DR: Exosomes are membrane-bound vesicles that are released by most cells and carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites as discussed by the authors .
Abstract: Exosomes are membrane-bound vesicles that are released by most cells. They carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites. They are responsible for inter- and intracellular communications and their role in drug delivery is well defined. Exosomes have great potential for therapeutic applications, but the clinical use is restricted because of limitations in standardized procedures for isolation, purification, and drug delivery. Bioengineering of exosomes could be one approach to achieve standardization and reproducible isolation for clinical use. Exosomes are important transporters for targeted drug delivery because of their small size, stable structure, non-immunogenicity, and non-toxic nature, as well as their ability to carry a wide variety of compounds. These features of exosomes can be enhanced further by bioengineering. In this review, possible exosome bioengineering approaches, their biomedical applications, and targeted drug delivery are discussed.

12 citations

Journal ArticleDOI
TL;DR: In this paper, the advanced bubble-based drug-delivery system, integrated with artificial intelligence for guidance, holds great promise for the targeted delivery of drugs and medicines, which can effectively circulate through the whole body safely and efficiently to reach the target area.
Abstract: Microbubbles are nanosized gas-filled bubbles. They are used in clinical diagnostics, in medical imaging, as contrast agents in ultrasound imaging, and as transporters for targeted drug delivery. They can also be used to treat thrombosis, neoplastic diseases, open arteries and vascular plaques and for localized transport of chemotherapies in cancer patients. Microbubbles can be filled with any type of therapeutics, cure agents, growth factors, extracellular vesicles, exosomes, miRNAs, and drugs. Microbubbles protect their cargo from immune attack because of their specialized encapsulated shell composed of lipid and protein. Filled with curative medicine, they could effectively circulate through the whole body safely and efficiently to reach the target area. The advanced bubble-based drug-delivery system, integrated with artificial intelligence for guidance, holds great promise for the targeted delivery of drugs and medicines.

12 citations

Journal ArticleDOI
TL;DR: In this article, heat shock protein 20 promotes sirtuin 1-dependent cell proliferation in induced pluripotent stem cells (iplus) in the presence of heat shock.
Abstract: Heat shock protein 20 promotes sirtuin 1-dependent cell proliferation in induced pluripotent stem cells

6 citations